IJMA | Atmaz Publishing Co.

The International Journal of Medical Advances (IJMA) is an international, peer-reviewed journal dedicated to publishing high-quality research that contributes to the advancement of medical science and healthcare practice. The journal covers a wide spectrum of disciplines including clinical medicine, pathology, surgery, pharmacology, radiology, public health, and medical education. IJMA welcomes interdisciplinary and methodologically diverse contributions, ranging from basic biomedical research to applied clinical studies, with a particular emphasis on innovations that improve patient care and healthcare delivery. It serves as a valuable platform for researchers, clinicians, and policymakers seeking evidence-based insights into the diagnosis, treatment, and prevention of disease in both developed and developing healthcare contexts.

Aims & Scope

The International Journal of Medical Advances (IJMA) aims to contribute to the advancement of medical knowledge by publishing high-quality, original research that addresses the evolving challenges and innovations in healthcare and medical science. The journal provides a platform for interdisciplinary scholarship that bridges clinical practice, biomedical research, and public health to improve patient outcomes and healthcare delivery worldwide.

IJMA welcomes contributions in core areas including clinical medicine, pathology, surgery, pharmacology, radiology, laboratory sciences, public health, and medical education. The journal encourages empirical studies, systematic reviews, theoretical frameworks, and case-based research that reflect the complex realities of modern medicine and healthcare systems.

The scope of IJMA includes, but is not limited to:

Advances in clinical medicine, diagnostics, and therapeutic interventions
Innovations in pathology, laboratory medicine, and precision diagnostics
Surgical techniques, minimally invasive procedures, and perioperative care
Pharmacology, drug development, and emerging therapeutics
Radiology, imaging technologies, and diagnostic advancements
Public health, epidemiology, and global health initiatives
Medical education, training methods, and curriculum development
Healthcare delivery systems, policy, and patient-centered care
Preventive medicine, lifestyle interventions, and chronic disease management
Translational research, clinical trials, and evidence-based practices

Through its broad and progressive scope, IJMA serves as a vital resource for researchers, clinicians, educators, and healthcare policymakers seeking to advance medical science and improve health outcomes across diverse populations and healthcare settings.

Peer Review Process

The International Journal of Medical Advances (IJMA) follows a rigorous and efficient double-blind peer review process designed to ensure academic quality and rapid publication. The journal is committed to transparency, fairness, and timeliness in the editorial process and makes every effort to complete the review and publication of accepted articles within four weeks (30 days) from the date of initial submission.

1. Initial Editorial Screening

All submitted manuscripts are first screened by the editorial office to verify their alignment with the journal's aims, scope, formatting requirements, and ethical guidelines. Manuscripts failing to meet these criteria may be returned to the authors without review.

2. Double-Blind Peer Review

Manuscripts passing the initial screening are subjected to double-blind peer review by at least two qualified experts in the field. The identities of authors and reviewers are kept confidential to preserve objectivity and impartiality.

Reviewers evaluate submissions based on:

Relevance to the journal's scope
Originality and contribution to knowledge
Theoretical and practical significance
Research design and methodological rigor
Quality of analysis and interpretation
Clarity, coherence, and scholarly writing

3. Decision and Feedback

Based on the reviewers' reports, the editorial decision will fall into one of the following categories:

Accept
Minor revisions required
Major revisions required
Reject

Authors receive a decision along with anonymous reviewer comments for revision, if applicable.

4. Revision and Resubmission

Revisions must address all reviewer concerns. Revised manuscripts may undergo a second round of review if necessary. The editorial team supports authors in resolving any issues promptly to maintain the targeted timeline.

5. Final Decision and Publication

Once a manuscript is accepted, it proceeds immediately to copyediting, typesetting, and publication. The journal makes every possible effort to finalize and publish accepted manuscripts within 30 days of initial submission, depending on the responsiveness of authors and reviewers.